Founded in early 2017, we are a next-generation healthcare IoT (HIoT) cybersecurity and intelligence company built in close partnership with hospitals, for hospitals.
proudly built in
Cylera's founding team met nearly 10 years ago at Cornell University in Ithaca, New York. In 2016, they came back together with the goal of developing new technology to change how hospitals and health systems manage the cybersecurity of their medical and IoT devices. In early 2017, Cylera was founded with a single mission: to safeguard patients. With headquarters and R&D in Manhattan, Cylera partnered with several hospitals and health systems in order to understand their unique challenges and begin developing new technology able to deliver value regardless of the existing network infrastructure, HIoT devices composition, program maturity, and more. Thanks to this close collaboration with healthcare leaders, Cylera achieved breakthroughs in technology that solve healthcare-specific challenges, leading to the creation of a next-gen HIoT cybersecurity platform now trusted by renowned hospitals and health systems across the U.S.
Our mission is simple: to safeguard what matters most – because we care about your patients as much as you do. For this reason, we’re unwavering in our dedication to drive the HIoT cybersecurity industry forward, and our people are equipped to carry out this mission. Cylera's team is made up of domain experts in cybersecurity, medical devices, clinical networks, data science, and analytics. We’re uncompromising in the quality of our solution and are focused on pushing the bounds of technology for the greater good of healthcare and patient safety.
Our research arm, Cylera Labs, is solely focused on the needs of the healthcare industry. We focus on finding proactive—not reactive—insights by leveraging a world class multidisciplinary team. Cylera Labs also conducts medical device vulnerability and research and is dedicated to responsible disclosures.
DICOM Images Have Been Hacked! Now What? published in The American Journal of Roentgenology on November 26, 2019. Contributing researches include Cylera's Markel Picado Ortiz, along with Benoit Desjardins, Yisroel Mirsky, Zeev Glozman, Lawrence Tarbox, Robert Horn and Steven C. Horii.
Cylera is actively supported by top-tier venture capital investors and industry leaders